The fact that China hasn’t approved any commercial GMO planting since 2009 reflects public fears.
David TalbotFollow @twitterapi
I’m MIT Technology Review's chief correspondent, keeping an eye most often on the world of information and communication technologies—and asking my kids when I don’t understand what’s going on. Recent projects have taken me to Kenya to write about mobile-phone-based health initiatives, and Germany to explore how they’ll ramp up renewable power while closing down nuclear plants. My 2008 feature on the Obama campaign’s social-networking operation was selected for The Best Technology Writing 2009.
David Talbot's Stories
Researchers have created wheat that is resistant to a common disease, using advanced gene editing methods.
Although it appears to hit incoming Hamas rockets, Israel’s system could be falling short of detonating the rockets' warheads.
New effort would pinpoint the source, type, and dispersal patterns of smog across Beijing to drive street-level predictions and targeted remediation.
A new process can cheaply clean extremely briny water coming up from oil wells.
Software could prevent sensitive medical data from being inadvertently shared as health records get passed around.
With emotion-triggering effort, Facebook pushes beyond data-driven studies on voting, sharing, and organ-donation prompts, to make people feel good or bad.
The Supreme Court’s decision was tailored narrowly, but it may provide openings for lawyers to argue that other forms of mass Internet streaming violate copyright.
A prototype device shows that measuring electrical resistance of tissues within the wrist could reliably identify someone.
A new wearable sensor listens for sounds that betray your activity and mood.